Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$36.81 - $48.12 $180,074 - $235,403
4,892 Added 10.16%
53,054 $2.19 Million
Q4 2022

Feb 14, 2023

SELL
$35.68 - $44.71 $41,674 - $52,221
-1,168 Reduced 2.37%
48,162 $1.99 Million
Q3 2022

Nov 14, 2022

SELL
$42.51 - $54.02 $639,988 - $813,271
-15,055 Reduced 23.38%
49,330 $2.16 Million
Q2 2022

Aug 12, 2022

SELL
$46.84 - $59.75 $23,045 - $29,397
-492 Reduced 0.76%
64,385 $3.17 Million
Q1 2022

May 16, 2022

BUY
$48.09 - $57.79 $387,364 - $465,498
8,055 Added 14.18%
64,877 $3.68 Million
Q4 2021

Feb 14, 2022

SELL
$47.19 - $62.68 $53,419 - $70,953
-1,132 Reduced 1.95%
56,822 $2.98 Million
Q3 2021

Nov 15, 2021

SELL
$56.91 - $67.81 $38,755 - $46,178
-681 Reduced 1.16%
57,954 $3.47 Million
Q2 2021

Aug 16, 2021

BUY
$64.02 - $71.72 $84,890 - $95,100
1,326 Added 2.31%
58,635 $3.97 Million
Q1 2021

May 14, 2021

SELL
$53.26 - $68.08 $107,052 - $136,840
-2,010 Reduced 3.39%
57,309 $3.76 Million
Q4 2020

Mar 01, 2021

BUY
$43.41 - $56.51 $169,342 - $220,445
3,901 Added 7.04%
59,319 $3.34 Million
Q3 2020

Nov 13, 2020

SELL
$47.43 - $60.75 $8,205 - $10,509
-173 Reduced 0.31%
55,418 $2.69 Million
Q2 2020

Aug 14, 2020

BUY
$43.51 - $66.59 $21,406 - $32,762
492 Added 0.89%
55,591 $3.09 Million
Q1 2020

May 15, 2020

SELL
$32.82 - $81.13 $70,136 - $173,374
-2,137 Reduced 3.73%
55,099 $2.79 Million
Q4 2019

Feb 14, 2020

BUY
$60.96 - $77.7 $145,877 - $185,936
2,393 Added 4.36%
57,236 $4.43 Million
Q3 2019

Nov 14, 2019

BUY
$55.78 - $68.08 $489,804 - $597,810
8,781 Added 19.06%
54,843 $3.48 Million
Q2 2019

Aug 15, 2019

BUY
$53.69 - $65.47 $239,672 - $292,258
4,464 Added 10.73%
46,062 $0
Q1 2019

May 14, 2019

BUY
$44.53 - $58.9 $213,966 - $283,014
4,805 Added 13.06%
41,598 $0
Q4 2018

Feb 13, 2019

BUY
$47.64 - $71.26 $81,226 - $121,498
1,705 Added 4.86%
36,793 $1.82 Million
Q3 2018

Nov 14, 2018

SELL
$52.03 - $71.41 $5,307 - $7,283
-102 Reduced 0.29%
35,088 $0
Q2 2018

Aug 14, 2018

SELL
$48.15 - $56.68 $63,702 - $74,987
-1,323 Reduced 3.62%
35,190 $0
Q1 2018

May 14, 2018

BUY
$46.03 - $61.28 $176,340 - $234,763
3,831 Added 11.72%
36,513 $0
Q4 2017

Feb 09, 2018

BUY
$50.58 - $60.79 $121,341 - $145,835
2,399 Added 7.92%
32,682 $0
Q3 2017

Nov 13, 2017

BUY
$53.54 - $68.0 $1.62 Million - $2.06 Million
30,283
30,283 $0

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.